|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 501/56 | (2006.01) |
| A61K 31/545 | (2006.01) | ||
| A61K 31/04 | (2006.01) |
| (11) | Number of the document | 1606293 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04720595.0 |
| Date of filing the European patent application | 2004-03-15 | |
| (97) | Date of publication of the European application | 2005-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2009-08-19 |
| (46) | Date of publication of the claims translation | 2009-12-28 |
| (86) | Number | PCT/EP2004/002667 |
| Date | 2004-03-15 |
| (87) | Number | WO 2004/085444 |
| Date | 2004-10-07 |
| (30) | Number | Date | Country code |
| 03006815 | 2003-03-27 | EP |
| (72) |
BERGHAUSEN, Joerg, DE
|
| (73) |
Basilea Pharmaceutica AG,
Grenzacherstrasse 487, 4005 Basel,
CH
|
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Kristalinės formos cefalosporinas |
| CEPHALOSPORIN IN CRYSTALLINE FORM |
| Payment date | Validity (years) | Amount | |
| 2019-02-19 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-03-15 |